Group 1 - The completion of the relocation settlement work for the Changqing resettlement housing project in the Cailhe unit has been achieved, providing housing for 136 households in the Qingya Hetangfu community [1] - The project consists of 12 high-rise buildings ranging from 10 to 24 stories, with a total above-ground construction area of 74,600 square meters, including 68,080 square meters for residential buildings and 6,520 square meters for supporting public buildings [1] - Other resettlement housing projects in Hangzhou, such as the Qiantang District, are also progressing well, with the second phase of the Xinyuan Street Xinyuan resettlement project expected to provide 576 resettlement houses [1] Group 2 - The Yipeng resettlement housing phase four project will cover an area of approximately 210,000 square meters, with a total construction area of 844,000 square meters, providing 3,998 resettlement houses in various sizes [2] - The project includes 43 high-rise residential buildings, supporting public facilities, a kindergarten, and a neighborhood center, significantly enhancing residents' quality of life [2] - In Fuyang District, the Chunbei D District resettlement housing project has completed its foundation work, with a total construction area of 89,050.77 square meters, including 43 residential units [2]

Group 1 - The core viewpoint of the news is the launch of the "South Wing New Ten Policies" aimed at fostering innovation and collaboration in the biotechnology sector within the Fuyang Economic and Technological Development Zone [1][2] - The "South Wing New Ten Policies" include support for industry-academia-research cooperation, intellectual property commercialization, and the establishment of AI public service platforms, among other initiatives [1][2] - Fuyang has 58 biopharmaceutical companies and is projected to achieve a revenue of 13.2 billion yuan in 2024, focusing on modern traditional Chinese medicine and other biopharmaceutical sectors [2][3] Group 2 - The event featured the signing of cooperation agreements between Fuyang and three biopharmaceutical innovation entities, indicating a collaborative approach to resource integration and innovation [2][3] - A total of over 2 billion yuan has been allocated to three funds focused on the biopharmaceutical sector, showcasing financial support for industry development [3] - The event also included the establishment of a patent navigation service base and a knowledge property alliance for the modern traditional Chinese medicine industry, aimed at enhancing intellectual property operations [3][4] Group 3 - The "Jiu San Chuang Ba" initiative has organized over 30 matchmaking events in key sectors, facilitating project roadshows and promoting the integration of innovation, industry, finance, and talent [4][5] - The event is seen as a practical implementation of the collaborative efforts between Fuyang and the West City Science and Technology Innovation Corridor, contributing to the high-quality development of the Yangtze River Delta region [5][6] - The Vice Chairman of the Provincial Political Consultative Conference emphasized the importance of cross-regional collaboration and the role of high-level intellectual resources in driving local development [6]

活动主会场，九三学社北京市企业家联谊会、九三学社杭州城西科创大走廊创新服务联盟、浙江之 江生命健康研究院与富阳经开区签署合作协议。同时，浙江省现代中医药产业专利导航服务基地、浙江 省现代中医药产业知识产权联盟揭牌暨富阳生物医药创新服务联盟集结仪式举行，6位在生物医药领域 具有深厚造诣和丰富实践经验的专家学者受聘担任富阳生物医药科技成果转化顾问。总规模超20亿元的 三只专注生物医药领域的基金（泰誉五期生命健康产业基金、圣诺医药-信远正合基金、汇鼎金石基 金）也与富阳达成合作。而生物医药公共服务平台、企业创新产品和城西科创大走廊及富阳联动区的前 沿成果相继发布，则全面展示了富阳在联廊发展过程中积累的科研实力和产业转化潜力，见证了从"政 策引育"到"成果涌现"的良性循环。 本次对接会还设立两个分会场——浙江省现代中医药产业知识产权联盟工作推进会暨"金种子"企 业、专利、成果对接会，聚焦知识产权运营与成果商业化，为科技成果产业化注入新动能；富阳区"潮 起富春"青年学者圆桌会，聚焦"医疗器械行业技术创新与机遇"，为富阳区医疗器械产业高质量发展凝 聚智慧力量。 9月9日下午，在富阳银湖科技城举行的"之江同心 九三创吧"城 ...

Core Points - The Hong Kong Stock Exchange (HKEX) Listing Committee decided on August 28 to maintain its decision regarding the company, indicating that it has failed to maintain sufficient business operations and does not possess adequate asset value to support its operations [1] - As a result of this decision, the company's shares will be suspended from trading starting at 9 AM today, with the last trading price recorded at HKD 0.36 [1] - The company must comply with the listing rules and any potential resumption guidelines set by HKEX before trading can resume; failure to trade for 18 consecutive months may lead to the cancellation of its listing status [1]

Core Viewpoint - The company has announced that its shares will be suspended from trading starting at 9 AM on September 9, 2025 [1] Group 1 - The suspension of trading is effective immediately as of the specified date and time [1]

格隆汇9月9日丨富阳(00352.HK)发布公告，该公司的股份将于今天(9/9/2025)上午九时正起暂停买卖。 ...

智通财经APP讯，富阳(00352)发布公告，公司股份将于2025年9月9日上午九时正起暂停买卖。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 Fortune Sun (China) Holdings Limited 富陽（中國）控股有限公司 （於開曼群島註冊成立之有限公司） 本 公 司 股 份 將 自 二 零 二 五 年 九 月 九 日 上 午 九 時 正 起 暫 停 於 聯 交 所 買 賣。 在 允 許 恢 復 買 賣 前，本 公 司 必 須： – 1 – (1) 重新符合上市規則第13.24條 之 規 定； (2) 達 成 聯 交 所 可 能 施 加 的 任 何 復 牌 指 引；及 (3) 使 聯 交 所 信 納 其 全 面 遵 守 上 市 規 則。 （股份代號：00352） 暫停股份買賣 本 公 告 乃 由 富 陽（中 國）控 股 有 限 公 司（「本公司」）根 據 香 港 聯 合 交 易 所 有 限 公 司 （「聯交所」）證 券 上 市 規 則（「上市規則」）第13.24條以及香 ...

智通财经APP讯，富阳(00352)发布公告，内容有关(其中包括)联交所上市委员会决定维持上市科根据上 市规则第13.24条所作出之决定。除非公司根据其于上市规则第2B.06(1)条项下所享有权利提交复核该决 定的申请，否则股份将自2025年9月9日(即上市委员会发出决定之日期后七个营业日届满)暂停买卖。经 过审慎考虑后，公司已决定放弃其于上市规则第2B.06(1)条项下提交复核申请的权利。因此，公司股份 将自2025年9月9日起暂停买卖。 在允许恢复买卖前，公司必须：(1)重新符合上市规则第13.24条之规定;(2)达成联交所可能施加的任何复 牌指引;及(3)使联交所信纳其全面遵守上市规则。 ...

在允许恢复买卖前，公司必须：(1)重新符合上市规则第13.24条之规定;(2)达成联交所可能施加的任何复 牌指引;及(3)使联交所信纳其全面遵守上市规则。 富阳(00352)发布公告，内容有关(其中包括)联交所上市委员会决定维持上市科根据上市规则第13.24条 所作出之决定。除非公司根据其于上市规则第2B.06(1)条项下所享有权利提交复核该决定的申请，否则 股份将自2025年9月9日(即上市委员会发出决定之日期后七个营业日届满)暂停买卖。经过审慎考虑后， 公司已决定放弃其于上市规则第2B.06(1)条项下提交复核申请的权利。因此，公司股份将自2025年9月9 日起暂停买卖。 ...